Who is Ankit Mahadevia? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Ankit Mahadevia is listed as CXO at Curie.Bio, based in United States, United States, United States. AeroLeads shows a work email signal at sperotherapeutics.com and a matched LinkedIn profile for Ankit Mahadevia.
Ankit Mahadevia previously worked as Member Board of Directors at Judo Bio and Advisor at Caper Bio. Ankit Mahadevia holds Md, Medicine from The Johns Hopkins University School Of Medicine.
Company email context
Email format at Curie.Bio
This section adds company-level context without repeating Ankit Mahadevia's masked contact details.
{first_initial}{last}@sperotherapeutics.com
89% confidence
AeroLeads found 2 current-domain work email signals for Ankit Mahadevia. Compare company email patterns before reaching out.
Profile bio
About Ankit Mahadevia
Entrepreneur, Board Member, Author, Physician Co-founder of nine biotech startups developing novel platforms and therapies, including Spero Therapeutics (Nasdaq:SPRO), Rodin Therapeutics (Acquired by Alkermes), and Arteaus Therapeutics (Acquired by Eli Lilly, Emgality FDA approved by Eli Lilly). Biotech Board member and advisor; Author of Quiet Leader Loud Results (Post Hill Press, 2022) www.quietleader.comSome more on my perspective at http://lifescivc.com/2014/04/building-great-startup-teams-in-biotech-a-three-hour-tour, http://lifescivc.com/2014/07/growing-beyond-the-startup-phase-lessons-learned, and at https://timmermanreport.com/2018/08/zigging-when-others-zag-speros-ankit-mahadevia-on-the-antibiotic-opportunity.
Listed skills include Venture Capital, Start Ups, Life Sciences, Biotechnology, and 13 others.
Current workplace
Ankit Mahadevia's current company
Company context helps verify the profile and gives searchers a useful next step.
20 roles · 25 years
Ankit Mahadevia work experience
A career timeline built from the work history available for this profile.
Member Board Of Directors
CurrentCreating oligonucleotide medicines delivered to the kidney, silencing target genes to treat systemic and renal diseases. Raised $100M Series A (Atlas, TCG, Droia, Digitalis).
Jun 2023 - Present
Advisor
Current
Caper Bio
Harnessing power of nutrition to address major unmet medical needs
Mar 2023 - Present
Advisor
Current
Vrata Bio
Oligonucleotide therapeutic platform addressing multiple unmet patient needs
Jun 2022 - Present
May 2024 - Present
Chairman
CurrentTransitioned to Chairman of Board 8/1/23 after 10 years as Founder and CEO. Developing novel treatments for serious infections. Built team responsible for 11 approved antibacterial drugs and raised $400M across private financings, IPO, public financings, and partnerships. Advanced three programs into late stage clinical trials. Completed $600M partnership.
Mar 2016 - Present
Jun 2023 - Present
Advisor
Current
Journey Colab
Developing next generation treatments for serious psychiatric disorders
Apr 2022 - Present
Advisor
Early stage life sciences and technology venture capital firm. Served as investment team member (2008-13), Venture Partner (2013-22), and Advisor (2022-23). Currently serve as BOD member for Atlas portfolio company.
2008 - 2023
~15 yrs
Co-Founder, Ceo, Board Of Directors
Synlogic, Inc.
Co-founder of next generation synthetic biology company inspired by the discoveries of Jim Collins and Tim Lu (Nasdaq: SYBX). Developing therapeutic microbes addressing high unmet medical needs, with the ability to tune therapeutic output based on environmental factors. As Acting CEO, secured seed investment from Atlas Venture in Fall 2013, and $30.4M.
Aug 2013 - Sep 2016
Co-Founder, Ceo, Board Of Directors
Developing therapies leveraging epigenetic mechanisms for treatment of unmet medical needs in the neurosciences. As Acting CEO, secured equity investment and collaboration with Johnson and Johnson Innovation Center in May 2013. Raised $12.9MM Series A Financing in May 2014, and completed $500M collaboration with Biogen.www.rodintherapeutics.com
Apr 2013 - Jul 2016
Advisory Council
National Center For Advancing Translational Sciences, National Institutes Of Health
VC representative of advisory board guiding program decision making. Co-chair of Pharma/VC collaborations subcommittee.
Sep 2011 - Sep 2015
Co-Founder, Board Of Directors
Translate Bio
Leveraging proprietary platform to develop therapeutics for gene up-regulation. Closed $20.5M Series A Financing with Atlas, SR One, and Monsanto.
Jul 2010 - Jul 2014
Co-Founder, Board Of Directors, Acting Cbo
Annovation Biopharma
Creating safer, more effective therapies for anesthesia and critical care. Closed investment and Option deal with The Medicines Company in September 2012. Company acquired by The Medicines Company in January 2015.
Apr 2011 - Jan 2013
Co-Founder, Acting Cbo
Arteaus Therapeutics
Developing anti-CGRP antibody for treatment of chronic migraine. Raised $18M from Atlas and Orbimed; secured license to asset and option deal with Eli Lilly. Antibody acquired by Eli Lilly in January 2014.
Sep 2010 - Oct 2011
Business Development
2007 - 2008
~1 yr
Business Development / Product Development
Arcion Therapeutics
Developing topical therapies for neuropathic pain
2006 - 2008
~2 yrs
Business Development
2007 - 2007
Associate
2006 - 2006
Consultant
Monitor Group
2001 - 2003
~2 yrs
3 education records
Ankit Mahadevia education
Md, Medicine
The Johns Hopkins University School Of Medicine
Mba, Health Care Management
The Wharton School
Ba, Summa Cum Laude With Honors, Economics/Biology
Northwestern University
FAQ
Frequently asked questions about Ankit Mahadevia
Quick answers generated from the profile data available on this page.
What company does Ankit Mahadevia work for?
Ankit Mahadevia works for Curie.Bio.
What is Ankit Mahadevia's role at Curie.Bio?
Ankit Mahadevia is listed as CXO at Curie.Bio.
What is Ankit Mahadevia's email address?
AeroLeads has found 2 work email signals at @sperotherapeutics.com for Ankit Mahadevia at Curie.Bio.
Where is Ankit Mahadevia based?
Ankit Mahadevia is based in United States, United States, United States while working with Curie.Bio.
What companies has Ankit Mahadevia worked for?
Ankit Mahadevia has worked for Curie.Bio, Judo Bio, Caper Bio, Vrata Bio, and Stealth Biotech.
How can I contact Ankit Mahadevia?
You can use AeroLeads to view verified contact signals for Ankit Mahadevia at Curie.Bio, including work email, phone, and LinkedIn data when available.
What schools did Ankit Mahadevia attend?
Ankit Mahadevia holds Md, Medicine from The Johns Hopkins University School Of Medicine.
What skills is Ankit Mahadevia known for?
Ankit Mahadevia is listed with skills including Venture Capital, Start Ups, Life Sciences, Biotechnology, Lifesciences, Business Development, Pharmaceutical Industry, and Entrepreneurship.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial